About BioSynchronicity
BioSynchronicity is a private company based in Spokane, Washington, incorporated in 2020 in Washington. It has reported $315,000 raised in five offerings on Form D since March 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Jul 22, 2024amended Dec 2, 2025 | $0of $1.0M target | 0 | — | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 21, 2023 | Jul 31, 2023 | $10,000of $800K target | 1 | $10,000 | EquityRule 506(b) | Form D ↗ |
| Jun 23, 2023 | Jun 28, 2023 | $25,000of $200K target | 2 | $12,500 | EquityRule 506(b) | Form D ↗ |
| Jul 7, 2022 | Jul 26, 2022 | $150,000of $300K target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Feb 16, 2021 | Mar 2, 2021 | $130,000of $300K target | 5 | $26,000 | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $315,000 | |||||
The filing for the offering first filed Jul 26, 2022 reports amount sold with no investors. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on BioSynchronicity's Form D filed Dec 2, 2025.